 |
 |
 |
|
|
VICE CHAIR DEPARTMENT of GLOBAL HEALTH
Dr. Wasserheit has had extensive experience in sexually transmitted disease (STD) research, policy development and program implementation both in the United States and in developing countries. Her research has included one of the first laparoscopic studies of pelvic inflammatory disease etiology conducted in the US, the first population-based study of the prevalence and etiologic spectrum of STDs among rural women in the Indian Subcontinent, and research on the interrelationships between STDs and contraceptive practices in other parts of the developing world, including Indonesia, and Egypt. She has also worked in Colombia, Thailand and Zambia. Her development of the concept of epidemiological synergy between HIV infection and other STDs has had a major influence on HIV prevention policy and programs around the world. Wasserheit has received numerous honors, including the Presidential Award from the American Social Health Association for outstanding work in the area of STD research. This year, she was elected to the Institute of Medicine, a section of the National Academy of Sciences. Wasserheit is committed to a multidisciplinary approach to global health. In a recent interview for UW Medicine magazine, she said, “If we're going to do this right, it means breaking out of the biomedical model and thinking more broadly about the larger sociocultural determinants of disease. Interview by Marjorie Wenrich & Marsha Rule |
|
| Acknowledgements | Disclaimer | For
DGH Employees School of Medicine | School of Public Health and Community Medicine |
© 2008 University of Washington. All Rights Reserved. |
Judith
N. Wasserheit MD, MPH is currently Professor of Global Health and Medicine
and Vice Chair of the Department of Global Health at the University of
Washington in the Schools of Medicine and Public Health & Community
Medicine. She is also an Affiliate Investigator at the Fred Hutchinson
Cancer Research Center. She was formerly the Director of the HIV Vaccine
Trials Network, a global clinical trials platform linking 28 sites on
four continents in evaluating preventive HIV vaccines.